Stabilux Biosciences
Ann Arbor, US · Michigan corporation · 2 known investors
Biotech
Founders & leadership
JL
JONATHAN LEINONENExecutive Officer, Director
YK
YOKE KHIN YAPExecutive Officer, Director
MM
MICHAEL MORTLOCKExecutive Officer
ME
MARK EHLERTDirector
ST
STEVE TOKARZExecutive Officer, Director
JR
JOHN RANSOMDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$554.4KraisedMay 2024 · 9 investors · BiotechnologyRule 506(b)
▶$554.4KraisedMay 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JONATHAN LEINONENExecutive Officer, Director
- YOKE KHIN YAPExecutive Officer, Director
- MICHAEL MORTLOCKExecutive Officer
- MARK EHLERTDirector
- STEVE TOKARZExecutive Officer, Director
- JOHN RANSOMDirector
- Offering amount
- $3M
- Amount sold
- $554.4K
- Proceeds to insiders
- $250K
- First sale
- Apr 2024
- Incorporated
- Corporation, Michigan
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.